Literature DB >> 27416114

Development of a biomarker scoring system for use in graft-versus-host disease.

Anne S Renteria1, John E Levine1, James L Ferrara2.   

Abstract

Keywords:  Ann Arbor score; algorithm; biomarkers; graft-versus-host disease (GVHD); treatment

Mesh：

Substances：

Year:  2016        PMID： 27416114      PMCID： PMC5493962          DOI： 10.2217/bmm-2016-0162

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  20 in total

1.  The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors.

Authors:  Carolyn Katovich Hurley; Ann Woolfrey; Tao Wang; Michael Haagenson; John Umejiego; Mahmoud Aljurf; Medhat Askar; Minoo Battiwalla; Jason Dehn; John Horan; Machteld Oudshoorn; Joseph Pidala; Wael Saber; Victoria Turner; Stephanie J Lee; Stephen R Spellman
Journal:  Blood       Date:  2013-05-01       Impact factor: 22.113

2.  Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.

Authors:  Luca Pastorelli; Rekha R Garg; Sharon B Hoang; Luisa Spina; Benedetta Mattioli; Melania Scarpa; Claudio Fiocchi; Maurizio Vecchi; Theresa T Pizarro
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

3.  Elafin is a biomarker of graft-versus-host disease of the skin.

Authors:  Sophie Paczesny; Thomas M Braun; John E Levine; Jason Hogan; Jeffrey Crawford; Bryan Coffing; Stephen Olsen; Sung W Choi; Hong Wang; Vitor Faca; Sharon Pitteri; Qing Zhang; Alice Chin; Carrie Kitko; Shin Mineishi; Gregory Yanik; Edward Peres; David Hanauer; Ying Wang; Pavan Reddy; Samir Hanash; James L M Ferrara
Journal:  Sci Transl Med       Date:  2010-01-06       Impact factor: 17.956

4.  A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.

Authors:  John E Levine; Thomas M Braun; Andrew C Harris; Ernst Holler; Austin Taylor; Holly Miller; John Magenau; Daniel J Weisdorf; Vincent T Ho; Javier Bolaños-Meade; Amin M Alousi; James L M Ferrara
Journal:  Lancet Haematol       Date:  2014-12-23       Impact factor: 18.959

5.  Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation.

Authors:  Cornelius Schmaltz; Onder Alpdogan; Stephanie J Muriglan; Barry J Kappel; Jimmy A Rotolo; Eric T Ricchetti; Andrew S Greenberg; Lucy M Willis; George F Murphy; James M Crawford; Marcel R M van den Brink
Journal:  Blood       Date:  2002-11-07       Impact factor: 22.113

6.  Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.

Authors:  James L M Ferrara; Andrew C Harris; Joel K Greenson; Thomas M Braun; Ernst Holler; Takanori Teshima; John E Levine; Sung W J Choi; Elisabeth Huber; Karin Landfried; Koichi Akashi; Mark Vander Lugt; Pavan Reddy; Alice Chin; Qing Zhang; Samir Hanash; Sophie Paczesny
Journal:  Blood       Date:  2011-10-06       Impact factor: 22.113

7.  Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model.

Authors:  Hitoshi Ogawa; Kouhei Fukushima; Hiroo Naito; Yuji Funayama; Michiaki Unno; Ken-ichi Takahashi; Taku Kitayama; Seiki Matsuno; Haruo Ohtani; Shin Takasawa; Hiroshi Okamoto; Iwao Sasaki
Journal:  Inflamm Bowel Dis       Date:  2003-05       Impact factor: 5.325

Review 8.  Graft-versus-host disease.

Authors:  James L M Ferrara; John E Levine; Pavan Reddy; Ernst Holler
Journal:  Lancet       Date:  2009-03-11       Impact factor: 79.321

9.  Peripheral-blood stem cells versus bone marrow from unrelated donors.

Authors:  Claudio Anasetti; Brent R Logan; Stephanie J Lee; Edmund K Waller; Daniel J Weisdorf; John R Wingard; Corey S Cutler; Peter Westervelt; Ann Woolfrey; Stephen Couban; Gerhard Ehninger; Laura Johnston; Richard T Maziarz; Michael A Pulsipher; David L Porter; Shin Mineishi; John M McCarty; Shakila P Khan; Paolo Anderlini; William I Bensinger; Susan F Leitman; Scott D Rowley; Christopher Bredeson; Shelly L Carter; Mary M Horowitz; Dennis L Confer
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

Review 10.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483
View more
  3 in total

1.  Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.

Authors:  George B McDonald; Laura Tabellini; Barry E Storer; Paul J Martin; Richard L Lawler; Steven L Rosinski; H Gary Schoch; John A Hansen
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-03       Impact factor: 5.742

2.  Prognostic values of increased B7 family proteins in haploidentical hematopoietic stem cell transplantation patients with aGVHD.

Authors:  Biqi Zhou; Tanzhen Wang; Lei Lei; Yutong Lu; Li Zhang; Xiaowen Tang; Huiying Qiu; Aining Sun; Xueguang Zhang; Yang Xu; Depei Wu
Journal:  Int J Hematol       Date:  2019-02-06       Impact factor: 2.490

3.  Analysis of the Whole CDR3 T Cell Receptor Repertoire after Hematopoietic Stem Cell Transplantation in 2 Clinical Cohorts.

Authors:  Omid Shah; John S Tamaresis; Laura Jean Kenyon; Liwen Xu; Pingping Zheng; Puja Gupta; Krish Rangarajan; Stephanie Lee; Stephen Spellman; Sarah Nikiforow; James Zehnder; Everett H Meyer
Journal:  Biol Blood Marrow Transplant       Date:  2020-02-18       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.